scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1011232327 |
P356 | DOI | 10.2165/00019053-199814030-00008 |
P698 | PubMed publication ID | 10186470 |
P2093 | author name string | J C McElnay | |
C O'Neill | |||
T A Maguire | |||
G E Crealey | |||
P2860 | cites work | Cost-effectiveness of nicotine gum as an adjunct to physician's advice against cigarette smoking | Q70302946 |
A comparison of psychological and pharmacological treatment in smoking cessation | Q70486443 | ||
Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling | Q71002324 | ||
Long-term outcome of smoking cessation workshops | Q71230030 | ||
Dollar estimates of the consequences of tobacco use in Canada, 1979 | Q71422355 | ||
Tobacco taxes and health care costs. Do Canadian smokers pay their way? | Q77702324 | ||
Mortality in relation to smoking: 40 years' observations on male British doctors | Q24648574 | ||
A cost-effectiveness analysis of self-help smoking cessation methods for pregnant women | Q34675168 | ||
Randomised controlled trial of nicotine chewing-gum | Q34761902 | ||
Effect of nicotine chewing gum as an adjunct to general practitioner's advice against smoking | Q34996333 | ||
Passive smoking and heart disease. Epidemiology, physiology, and biochemistry | Q35009066 | ||
The costs of smoking and the cost effectiveness of smoking-cessation programs | Q37818639 | ||
The effectiveness of smoking cessation advice given during routine medical care: physicians can make a difference. | Q38594017 | ||
Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement | Q39486649 | ||
An evaluation of current methods of modifying smoking behavior | Q39947920 | ||
Using cost-effectiveness/cost-benefit analysis to allocate health resources: a level playing field for prevention? | Q40914775 | ||
Discounting and health benefits | Q41120784 | ||
Cigarette smoking and lifetime medical expenditures | Q41129093 | ||
The social costs of tobacco smoking | Q41219589 | ||
The economic costs of smoking and benefits of quitting for individual smokers | Q41427879 | ||
Controlled trial of three different antismoking interventions in general practice | Q41844194 | ||
The cost-effectiveness of counseling smokers to quit. | Q45992034 | ||
The economic costs of the health effects of smoking, 1984. | Q46591233 | ||
The taxes of sin. Do smokers and drinkers pay their way? | Q47943153 | ||
Health and economic implications of a tobacco-free society | Q47946684 | ||
Effects of nicotine chewing gum and follow-up appointments in physician-based smoking cessation | Q49011071 | ||
Mass media based health behavior change: televised smoking cessation program | Q49032194 | ||
Mortality from tobacco in developed countries: indirect estimation from national vital statistics. | Q50541120 | ||
How much can business expect to profit from smoking cessation? | Q50585100 | ||
Does smoking increase medical care expenditure? | Q50585201 | ||
The cost-effectiveness of the nicotine transdermal patch for smoking cessation. | Q50964894 | ||
Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice. | Q51128120 | ||
The cost-effectiveness of three smoking cessation programs. | Q52941649 | ||
Effect of general practitioners' advice against smoking. | Q52961336 | ||
Cost-effectiveness of a smoking cessation program after myocardial infarction. | Q53673992 | ||
The costs of smoking revisited | Q68187896 | ||
Attributes of successful smoking cessation interventions in medical practice. A meta-analysis of 39 controlled trials | Q68350685 | ||
Controlled trial of transdermal nicotine patch in tobacco withdrawal | Q69366999 | ||
More on the impact of smoking on medical care expenditures | Q69973781 | ||
Stopping smoking after myocardial infarction | Q70008412 | ||
A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation | Q70201232 | ||
Life expectancies of cigarette smokers and nonsmokers in the United States | Q70226221 | ||
P433 | issue | 3 | |
P921 | main subject | pharmacy | Q614304 |
P304 | page(s) | 323-333 | |
P577 | publication date | 1998-09-01 | |
P1433 | published in | PharmacoEconomics | Q7180778 |
P1476 | title | Costs and effects associated with a community pharmacy-based smoking-cessation programme | |
P478 | volume | 14 |